GlassScriptPhysician profile
Ziad Kronfol
NPI 1871750984
$81,196.63
in general payments reported to CMS, 2019-2025
16 companies · $25K in 2025
The $25K reported for 2025 was more than what 96% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $783 · 2021: $386 · 2022: $890 · 2023: $17K · 2024: $27K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $50K · Travel and Lodging: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Food and Beverage: $3,284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $50,000.00 |
| Travel and Lodging | $10,952.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Food and Beverage | $3,283.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $77,765.53 | 2019-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,571.44 | 2019 | |
| Applied Medical Resources Corporation | $730.18 | 2020 | |
| Ethicon US, LLC | $354.52 | 2019-2023 | Echelon Circular, Echelon Flex, Harmonic |
| Medtronic, INC. | $251.19 | 2022-2025 | Signia, Endo Gia Ultra |
| Tela Bio, INC. | $153.14 | 2021 | |
| Axonics, INC. | $100.02 | 2021-2022 | |
| Hologic Sales and Service, LLC | $48.92 | 2024-2025 | Coolseal Generator |
| Baxter Healthcare | $48.90 | 2025 | Perclot |
| Takeda Pharmaceuticals U.S.A., INC. | $37.42 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $29.19 | 2022-2023 | Seglentis |
| Eisai INC. | $27.56 | 2024 | |
| Davol INC. | $22.38 | 2022 | |
| Endo Pharmaceuticals INC. | $19.81 | 2019 | |
| Myriad Genetic Laboratories, INC. | $18.73 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $17.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ziad Kronfol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.